Skip to main content
. 2020 Sep 17;5(3):45. doi: 10.3390/biomimetics5030045

Figure 6.

Figure 6

Antimicrobial disc dilution assay of biocomplexes with positive controls (antibiotic). From left to right: AV-PVP-I2 against (a) S. aureus ATCC 25923; (b) P. aeruginosa WDCM 00026; (c) B. subtilis WDCM 00003. From (d,e): AV-PVP-I2-NaI against (d) S. aureus ATCC 25932; (e) B. subtilis WDCM 00003; (f) AV-PVP-I2, AV-PVP-NaI and AV-PVP-NaI against S. pyogenes ATCC 19615. From (gi): Susceptibility of C. albicans WDCM 00054 towards (g) AV-PVP-I2 (25 µg/mL); (h) AV-PVP-I2-NaI (50 µg/mL); (i) AV-PVP-I2-NaI (D = 6 µg/mL, E = 3 µg/mL, F = 1.5 µg/mL).